Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEmpyrean Regulatory News (EME)

Share Price Information for Empyrean (EME)

Share Price is delayed by 15 minutes
Get Live Data
0.0575    0.00 (0.00%)
Bid:
0.055
Ask:
0.06
Spread: 0.005 (9.091%)
Market Cap: £3.29m
EME Live PriceLast checked at - London Stock Exchange

Intraday Empyrean Share Chart

Trading Statement

27 May 2008 07:00

RNS Number : 2704V
Empyrean Energy PLC
27 May 2008
Β 

Empyrean Energy PLCΒ 

("Empyrean" or the "Company"; Ticker: (EME))

Sugarloaf Prospect,Β ("Sugarloaf"), Block B,Β Β TexasΒ USA

Β 

Β 

Kennedy #1 well flows gas and condensate from a new pay zone

New pay zone is 120 feet thick versus 80 feet thick upper zone already producing from two wells in Block A

This test aloneΒ could more than doubleΒ the potential recoverable reserves from the project

Β 

Empyrean, the AIM listed oil and gas explorer and producer with assets inΒ GermanyΒ andΒ USAΒ today announces the following:

Kennedy #1Β WellΒ 

EmpyreanΒ has been advised by Texas Crude EnergyΒ IncorporatedΒ ("TCEI"), the operator ofΒ Block BΒ on the Sugarkane Gas and Condensate field, that production tubing has been successfully installed in KennedyΒ #1Β and the well has been flowed and placed back onΒ well test. The reservoir stimulation program on the KennedyΒ #1Β well commenced on 14 May, 2008 with the hydraulic fracture stimulation ("frac") of an approximate 600 ft zone at the end of the horizontal section of the well via four sets of perforations.

As at 0600hrs (US CST) on theΒ 25thΒ May 2008 the well had produced a total of 1,274 bbls of fracture fluids, 257 bbls of condensate and is continuing to produce small quantities ofΒ gasΒ and condensate. With the production tubing now in place there are several options available to accelerate the recovery of fracture fluid and the potential for additional fracture stimulation along the horizontal section of the well will also be considered.Β 

Commenting today, Empyrean Executive Director Tom Kelly said "This is very encouraging news for the project as a whole because we now may have approximately 150% larger potential recoverable volumesΒ when you add this new "middle pay zone" to the "upper pay zone"Β thatΒ we had already proven commercialΒ from theΒ testing of the Block A wells. Significantly, this test at Kennedy was a relatively small fracture stimulation conducted over a relatively small horizontal section of the well and we would expect thatΒ much better flow rates can be achievedΒ usingΒ knowledge gained from these early wells. The completion technique used on this most recentΒ testΒ should measurably improve the production ratesΒ forΒ theΒ third potential pay zone, a lower zone some 50 feet thick,Β whichΒ was initially tested by the Sugarloaf-1 vertical well."

Further releasesΒ will be made as appropriate.

The informationΒ contained in this announcement was completed and reviewed by the Technical Director ofΒ Empyrean Energy Plc, Mr Frank Brophy BSc (Hons) who has over 40 years experience as a petroleum geologist.

For further information:Β 

Β 

Empyrean Energy plcΒ 

Tel: +44(0) 207 182 1746Β 

Β 

Rod Venables / Cecil JordaanΒ 

HB CorporateΒ 

Tel: +44(0) 207 510 8600Β 

Β 

Jonathan Charles / Ed PortmanΒ 

Conduit PRΒ 

Tel: +44 (0) 207 429 6611 / +44 (0) 7791 892 509Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
DRLGUGDUCSDGGIR
Date   Source Headline
5th Feb 20252:47 pmRNSHolding(s) in Company
30th Jan 20257:00 amRNS£675,000 Placing
28th Jan 20253:39 pmRNSHolding(s) in Company
28th Jan 20257:50 amRNSLand access agreement for Wilson River 1 secured
23rd Jan 20257:00 amRNSParticipation option in the Wilson River prospect
6th Jan 20257:00 amRNSHolding(s) in Company
18th Dec 20247:00 amRNSInterim Results
4th Dec 20247:00 amRNSHolding(s) in Company
2nd Dec 202412:14 pmRNSResults of General Meeting
13th Nov 20247:00 amRNSPosting of Circular
12th Nov 20249:00 amRNSChange of Registered Office Address
11th Nov 202410:15 amRNSResults of Retail Offer
6th Nov 20247:22 amRNSRetail Offer
6th Nov 20247:00 amRNSProposed Fundraise and Capital Reorganisation
28th Oct 202412:11 pmRNSResults of General Meeting
8th Oct 20249:19 amRNSHolding(s) in Company
2nd Oct 202411:05 amRNSPosting of Annual Report and Notice of GM
1st Oct 20247:00 amRNSFinal Results
30th Sep 202410:48 amRNSResult of AGM
19th Sep 20244:14 pmRNSHolding(s) in Company
4th Sep 20241:36 pmRNSPosting of Notice of Annual General Meeting
2nd Sep 20247:00 amRNSGas Sale Agreement Signed with Sembcorp
22nd Aug 20249:02 amRNSBoard Restructure
26th Jul 20248:30 amRNSIssue of Salary Sacrifice Shares
24th Jun 20247:00 amRNSMako Binding Gas Sale Agreement Signed with PGN
13th Jun 20247:00 amRNSBlock 29/11 China update
5th Apr 20247:00 amRNSDirector/PDMR Shareholding
28th Mar 20247:57 amRNSMako Gas Sale Key Terms Signed with PGN
23rd Feb 20247:39 amRNSMinisterial Approval of Mako Gas Price
13th Feb 20247:00 amRNSEmpyrean completes £700,000 Placing
31st Jan 20247:00 amRNSDuyung PSC Update
18th Dec 202311:34 amRNSInterim Results
20th Nov 20232:40 pmRNSChange of Nominated Adviser
27th Sep 202312:58 pmRNSResult of AGM
15th Sep 20237:00 amRNSIssue of Salary Sacrifice Shares
12th Sep 20237:13 amRNSKey Terms Agreed for Long-Term Gas Sales Agreement
4th Sep 20237:00 amRNSPosting of Annual Report and Notice of AGM
1st Sep 202312:30 pmRNSFinal Results
30th May 20237:36 amRNSCapital raising, Debt Restructure & Company Update
2nd May 20237:00 amRNSMako gas field - Update
4th Jan 20234:40 pmRNSSecond Price Monitoring Extn
4th Jan 20234:35 pmRNSPrice Monitoring Extension
3rd Jan 20234:40 pmRNSSecond Price Monitoring Extn
3rd Jan 20234:35 pmRNSPrice Monitoring Extension
20th Dec 20227:00 amRNSInterim Results
23rd Nov 20224:36 pmRNSPrice Monitoring Extension
8th Nov 20227:00 amRNSMako Gas - Approval of Updated Plan of Development
19th Oct 20221:19 pmRNSResults of General Meeting
27th Sep 202212:54 pmRNSResult of AGM
26th Sep 202212:01 pmRNSPosting of Annual Report and Notice of GM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.